PreppinPeppers › Facts › Lab article
Survodutide: Reference Overview and Reconstitution Notes
Machine-readable facts for this Lab article. The full page is https://www.preppinpeppers.com/blogs/the-lab/survodutide.
TL;DR
Survodutide (BI 456906) is an investigational glucagon-based peptide with a fatty acid chain, a dual glucagon and GLP-1 receptor agonist. Reference notes.
Facts Index
| Fact ID | Category | Entity | Attribute | Value | Source |
|---|---|---|---|---|---|
| survodutide:title | identity | Survodutide: Reference Overview and Reconstitution Notes | title | Survodutide: Reference Overview and Reconstitution Notes | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:published | identity | Survodutide: Reference Overview and Reconstitution Notes | published | 2026-07-10 | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:author | identity | Survodutide: Reference Overview and Reconstitution Notes | author | Preppin' Peppers Editorial Team | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:topics | identity | Survodutide: Reference Overview and Reconstitution Notes | topics | Investigational, research | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:summary | content | Survodutide: Reference Overview and Reconstitution Notes | summary | Survodutide (BI 456906) is an investigational glucagon-based peptide with a fatty acid chain, a dual glucagon and GLP-1 receptor agonist. Reference notes. | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-1 | content | Survodutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-2 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Survodutide | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-3 | content | Survodutide: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-4 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Research context and categorization | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-5 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Status | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-6 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Reconstitution notes (general) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-7 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Dilution and handling notes (compound-specific) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-8 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Handling and storage | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-9 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Related reading | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-10 | content | Survodutide: Reference Overview and Reconstitution Notes | section | Tools and supplies | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:section-12 | content | Survodutide: Reference Overview and Reconstitution Notes | section | What the research community gets wrong about survodutide | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:product-gansulin-metal-peptide-pen | products | Survodutide: Reference Overview and Reconstitution Notes | references product | Gansulin Pen ยท Reusable Click-Dial, 3 ml (1-60 Units) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:product-gansulin-3ml-cartridge | products | Survodutide: Reference Overview and Reconstitution Notes | references product | Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:source-pubchem-ncbi-nlm-nih-gov | source | Survodutide: Reference Overview and Reconstitution Notes | cites | NCBI PubChem CID 168429725: Survodutide (C192H289N47O61) - pubchem.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:source-pubmed-ncbi-nlm-nih-gov | source | Survodutide: Reference Overview and Reconstitution Notes | cites | Sanyal et al., N Engl J Med 2024: A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:source-pubmed-ncbi-nlm-nih-gov-2 | source | Survodutide: Reference Overview and Reconstitution Notes | cites | le Roux et al., Lancet Diabetes Endocrinol 2024: Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:source-pubmed-ncbi-nlm-nih-gov-3 | source | Survodutide: Reference Overview and Reconstitution Notes | cites | Drucker, Diabetes Care 2024: Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:source-pubmed-ncbi-nlm-nih-gov-4 | source | Survodutide: Reference Overview and Reconstitution Notes | cites | Son et al., Endocr Rev 2026: Novel GLP-1-based Medications for Type 2 Diabetes and Obesity - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
| survodutide:source-www-uniprot-org | source | Survodutide: Reference Overview and Reconstitution Notes | cites | UniProtKB/Swiss-Prot P43220: Glucagon-like peptide 1 receptor (GLP1R, Homo sapiens), UniProt release 2026-03 - www.uniprot.org | Lab article (https://www.preppinpeppers.com/blogs/the-lab/survodutide) (evidence) |
FAQ
- What receptors does survodutide target?
- Survodutide is a dual agonist designed to activate both the GLP-1 receptor and the glucagon receptor (GCGR) simultaneously. Its glucagon-based structure includes an attached fatty chain that extends its duration of activity.
- What is the regulatory status of survodutide?
- Survodutide is investigational and not FDA-approved for any use. It holds FDA Breakthrough Therapy designation for non-cirrhotic MASH with fibrosis, which can expedite review but is not itself an approval.
- How is lyophilized survodutide reconstituted for laboratory research?
- Lyophilized survodutide powder is reconstituted by slowly introducing bacteriostatic water into the vial, gently swirling until fully dissolved, then visually inspecting for clarity and particulates before lab use.